• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

leon-nanodrugs, Bionpharma to develop microjet reactor-based dermatological product

January 17, 2017 By Sarah Faulkner

leon-nanodrugs, Bionpharma to develop microjet reactor-based dermatological productleon-nanodrugs GmbH and Bionpharma Inc. said yesterday that the 2 groups inked a deal to develop a dermatological product using leon-nanodrugs’ microjet reactor nanotechnology platform.

The companies will share the development of the undisclosed product. Development will be done at leon-nanodrugs’ U.S.-based formulation partner CoreRx in Clearwater, Florida. Bionpharma will market and distribute the product in the U.S. and other markets.

leon-nanodrugs’ microjet reactor technology is used to reformulate active pharmaceutical ingredients that are poorly soluble in water. The company touts its 1-step process as highly cost effective and easily scalable.

“We are very pleased about the partnership with Bionpharma who share our vision to generate added value to therapeutic molecules through the unique attributes of our MicroJet Reactor Technology,” leon-nanodrugs CEO Michael Mehler said in prepared remarks. “In addition this co-development is a key strategic step on our way to become a recognized global leader in nanotechnology formulated pharmaceuticals.”

“Bionpharma strives to bring uniquely formulated products to the market and this association with leon-nanodrugs is a big step towards this endeavor,” Bionpharma president & CEO Venkat Krishnan added.

Filed Under: Featured, Nanoparticles, Research & Development, Wall Street Beat Tagged With: Bionpharma Inc., leon-nanodrugs GmbH

IN CASE YOU MISSED IT

  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications
  • Go-Pen ApS wins FDA nod for user-filled insulin pen

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS